Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity

Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity

Abstract Background Interleukin-35 (IL-35) has been reported to play an important role in the progression of cancers. The role of IL-35 in prostate cancer (PCA) is not well understood. In this study, we investigated the effects of IL-35 on PCA and its immunoregulatory effect on PCA. Methods The prot...

Full description

Bibliographic Details
Main Authors: Jialin Zhu, Yan Wang, Dai Li, Haonan Zhang, Zhi Guo, Xueling Yang
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Cancer Cell International
Subjects:
Interleukin-35
Prostate cancer
Proliferation
Angiogenesis
Anti-tumour immunity
Online Access:http://link.springer.com/article/10.1186/s12935-020-01583-3

Internet

http://link.springer.com/article/10.1186/s12935-020-01583-3

Similar Items